IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION
F. Peccatori et al., IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION, Blood, 90(10), 1997, pp. 4381-4381